Rev. Professor Lesley Stanley - Register of Interests

Direct employment.

Self-employed as Consultant in Investigative Toxicology (sole trader); May 2005 – present.

Teachers Pensions Agency (occupational pension); October 2022 – present.

Consultancies and other fee-paid work.

Completed consultancy for Dundee Medical School - preparation of primary research paper on the 8HUM humanised mouse model for publication in Journal of Pharmacology and Experimental Therapeutics; February – December 2024.

Completed consultancy for UK Health and Safety Executive, Agency for UK REACH – RISEP Authorisation Challenge Panels (occasional); December 2023 – February 2025.

Completed consultancy for Deltohn Ltd, Builth Wells, LD2 3RX – project management support (occasional); 2022 – present.

Completed consultancy for UK Health and Safety Executive, Agency for UK REACH – RISEP Restriction Challenge Panels. Moderator for RP003, Tattoo Inks; Challenge Panel Member for RP004, Lead in Ammunition; July 2022 – December 2024.

Completed consultancy for UK Health and Safety Executive, Agency for UK REACH – RISEP Dossier Review Group for proposed PFAS restriction; June – July 2025.

Shareholdings.

Investment Portfolio managed by Schroders Personal Wealth; 2023 – present.

Investment Portfolio managed by Quilter Cheviot (joint with spouse); 2018 – present.

Stocks and Shares ISA managed by Teesside Financial; 2005 – present.

Personal Pension Plan managed by Teesside Financial; 2002 – present.

Clubs, other organisations and advocacy groups.

Fellow of the British Toxicology Society (FBTS); 2018 – present

European Registered Toxicologist (ERT); 2005  present.

Other personal interests.

Paid travel to meetings/conferences

I received a bursary of £500 from the UK Register of Toxicologists for attendance at the British Toxicology Society Annual Congress (2023).

Charitable donations (>£500 in any year)

I am a regular donor to the following charities:

Christian Aid In Their Lifetime programme (joint with spouse); monthly since 2009.

International Justice Mission (joint with spouse); monthly since 2015.

Emmanuel Healthcare (joint with spouse); monthly since 2015.

Buchlyvie and Gartmore Parish Church (joint with spouse); monthly since 2011.

I also make intermittent one-off donations:

Embrace the Middle East; 2024 & 2025.

Christian Solidarity Worldwide; 2024 & 2025.

Royal Foundation of St Katharine; March 2024.

Friends of Sabeel UK; March 2025

Fellowships.

None.

Indirect support.

None.

Trusteeships.

Trustee of the Church of Scotland Presbytery of Perth since 1^st January 2022.

Land and property.

None.

Other public appointments.

Chair of the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment; 2025 – present.

Member of the REACH Independent Scientific Expert Pool (RISEP); 2022 – present.

Member of the OPSS Register of Specialists; 2021 – present.

Member of the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC); 2020 – present.

Member of the Advisory Committee on Novel Foods and Processes (ACNFP); 2016 – present (currently co-opted for matters concerning cannabidiol.

Other non-personal interests.

Non-stipendiary appointments

Visiting Professor at School of Life Sciences, Edinburgh Napier University; 2024 – present.

Finance and Stewardship Convener, Presbytery of Perth (Church of Scotland); 2025 – present.

Ordained Local Minister, Church of Scotland; 2021 – present.

Honorary Chaplain, University of Stirling; 2021 – present.

Direct employment.

Associate of Edinburgh Napier University (non-stipendiary position) with occasional short-term employment; 2015–2024.

Employed at Deltohn Ltd, Builth Wells, LD2 3RX – six months’ part-time employment contract; 2023.

Employed as Head of Operations at CXR Biosciences Ltd, Dundee; 2002–2005.

Consultancies and other fee-paid work.

Completed unpaid consultancy for PhaSER, potential company aiming to provide drug-drug interaction prediction services using 8HUM cytochrome P450 humanised mice – Informal consultancy; 2022*.

Completed consultancy for Office for Product Safety and Standards – Peer review of OPSS rapid literature review report on human health effects of Melanotan II (Ad Hoc consultancy commission); 2022. 

Completed consultancy for Dundee Medical School – Preparation of review on HepG2 and HepaRG cell lines for publication in Drug Metabolism Reviews; 2021 – 2022.

Completed consultancy for Dundee Medical School – Support with REF2021 Impact Cases; 2021 - 2022.

*Details of other unpaid consultancy work and commissions prior to January 2020 are provided in LAS master project list spreadsheet (appended).

Shareholdings.

None.

Clubs, other organisations and advocacy groups.

None.

Other personal interests.

Panellist of the UK Register of Toxicologists 2009–2018; Vice-Chair from 2012-2015; Chair for three years to the end of 2018.

Sole author of Molecular and Cellular Toxicology: An Introduction, published by Wiley-Blackwell, Chichester, UK; 2014.

Fellowships.

None.

Indirect support.

None.

Trusteeships.

None.

Land and property.

None.

Other public appointments.

Member of the Scottish Food Advisory Committee; 2009–2015.

Member of the Hazardous Substances Advisory Committee; 2007–2016.

Member of the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT); 2001–2007.

Other non-personal interests.

None.